Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	781.59	167.77	-19.03
Graham Fair Price	-68.92	41.96	134.98
PEG	10428.72	-0.23	< 0.005
Price/Book	-4.18	0.75	0.79
Price/Cash Flow	-1.48	42.90	43.54
Prices/Earnings	908.35	24.87	-2.47
Price/Sales	-10.52	17.36	19.40
Price/FCF	-1.48	42.90	43.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-28.97	0.31	0.43
Operating Margin	-90.24	0.26	-2.63
ROA	-90.48	< 0.005	-0.03
ROE	-0.08	< 0.005	-90.50
ROIC	-0.04	< 0.005	-89.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-39.52
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-6.18	1.11	-82.11
EPS QOQ	-11.44	1.10	-90.42
FCF QOQ	2.29	-0.02	-99.16
Revenue QOQ	-0.03	0.08	199.55
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.50	10.58	322.51
Days Sales Outstanding (DSO)	16.49	3.03	-81.65
Inventory Turnover	35.94	8.51	-76.33
Debt/Capitalization	0.56	0.55	-0.40
Quick Ratio	0.43	0.36	-16.69
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	100.71	101.54	0.83
Cash	3.71	3.85	3.60
Capex	-0.08	-0.03	67.74
Free Cash Flow	1.82	1.79	-1.93
Revenue	4.09	4.42	7.99
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.83	0.85	3.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-11.56	103.23	792.81
Naive Interpretation	Member

06 - Financial Health · Bad

Rating